NCT06065540 · Interventional trial
A Research Study to See How Well CagriSema Compared to Semaglutide, Cagrilintide and Placebo Lowers Blood Sugar and Body Weight in People With Type 2 Diabetes Treated With Metformin With or Without an SGLT2 Inhibitor
Overall registry status Completed
Phase 3
Conditions Type 2 Diabetes Mellitus
Delaware Valley sites
- Premier Research Inc. · Trenton, NJ · Mercer County
First posted
Registry updated
Added to the directory